Edition:
United States

Health News

AbbVie rheumatoid arthritis drug succeeds in late stage trial

AbbVie Inc on Tuesday said its experimental rheumatoid arthritis (RA) treatment showed significant improvement in physical function, pain and quality of life compared with the commonly prescribed generic drug methotrexate in a late stage clinical trial.

Health Reform Watch